Diabetic retinopathy is a leading cause of preventable blindness, yet many patients miss their annual eye exam for diabetes due to barriers in access, time, and awareness.
Join Michael Abramoff, MD, PhD, Founder and Executive Chairman of Digital Diagnostics and Dr. Kathleen Provanzana, Medical Director at OhioHealth as they discuss how OhioHealth is transforming diabetic retinopathy testing with LumineticsCore®, an autonomous AI solution that provides real-time, point-of-care results.
The session will explore:
- The impact of diabetic retinopathy and testing challenges in primary care
- Why OhioHealth selected AI-powered diabetic retinopathy detection
- Real-world outcomes - workflow efficiency, patient access, clinical impact, and patient outcomes
- Lessons learned and best practices for scaling AI-driven testing in healthcare
This webinar is built for decision-makers who want to maximize impact without overburdening staff or patients.